DE60142615D1 - Epitop-synchronisierung in antigen präsentierenden zellen - Google Patents
Epitop-synchronisierung in antigen präsentierenden zellenInfo
- Publication number
- DE60142615D1 DE60142615D1 DE60142615T DE60142615T DE60142615D1 DE 60142615 D1 DE60142615 D1 DE 60142615D1 DE 60142615 T DE60142615 T DE 60142615T DE 60142615 T DE60142615 T DE 60142615T DE 60142615 D1 DE60142615 D1 DE 60142615D1
- Authority
- DE
- Germany
- Prior art keywords
- housekeeping
- disclosed
- cells
- presenting cells
- epitop
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000004027 cell Anatomy 0.000 abstract 5
- 229960005486 vaccine Drugs 0.000 abstract 4
- 230000028993 immune response Effects 0.000 abstract 2
- 230000002093 peripheral effect Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 210000000612 antigen-presenting cell Anatomy 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 244000000056 intracellular parasite Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56157100A | 2000-04-28 | 2000-04-28 | |
US56046500A | 2000-04-28 | 2000-04-28 | |
US56157200A | 2000-04-28 | 2000-04-28 | |
US09/561,074 US6861234B1 (en) | 2000-04-28 | 2000-04-28 | Method of epitope discovery |
PCT/US2001/013806 WO2001082963A2 (en) | 2000-04-28 | 2001-04-27 | Method of identifying and producing antigen peptides and use thereof as vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60142615D1 true DE60142615D1 (de) | 2010-09-02 |
Family
ID=27504814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60142615T Expired - Lifetime DE60142615D1 (de) | 2000-04-28 | 2001-04-27 | Epitop-synchronisierung in antigen präsentierenden zellen |
Country Status (13)
Country | Link |
---|---|
US (1) | US20070269464A1 (de) |
EP (4) | EP2278023A1 (de) |
JP (1) | JP2003535824A (de) |
CN (1) | CN1440462A (de) |
AT (1) | ATE474931T1 (de) |
AU (3) | AU5741001A (de) |
CA (1) | CA2405363A1 (de) |
DE (1) | DE60142615D1 (de) |
DK (1) | DK1276896T3 (de) |
ES (1) | ES2347762T3 (de) |
HK (1) | HK1053333A1 (de) |
NZ (1) | NZ521715A (de) |
WO (1) | WO2001082963A2 (de) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
US6977074B2 (en) | 1997-07-10 | 2005-12-20 | Mannkind Corporation | Method of inducing a CTL response |
US20030138808A1 (en) * | 1998-02-19 | 2003-07-24 | Simard John J.L. | Expression vectors encoding epitopes of target-associated antigens |
US20030215425A1 (en) * | 2001-12-07 | 2003-11-20 | Simard John J. L. | Epitope synchronization in antigen presenting cells |
US6773695B2 (en) * | 2000-10-05 | 2004-08-10 | Mannkind Corporation | Modulation of allergic response |
EP1595548A3 (de) * | 2001-03-07 | 2006-02-22 | Mannkind Corporation | Anti-Neovaskulatur Präparationen zur Krebsbehandlung |
CN100589845C (zh) * | 2001-03-07 | 2010-02-17 | 麦康公司 | 用于治疗癌症的抗新血管系统制剂 |
WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
EP1752160A3 (de) | 2001-04-06 | 2007-05-30 | Mannkind Corporation | Epitop-Sequenzen |
AU2008229888B2 (en) * | 2001-11-07 | 2012-07-05 | Mannkind Corporation | Expression vectors encoding epitopes of target-associated antigens and methods for their design |
CN101024842A (zh) * | 2001-11-07 | 2007-08-29 | 曼康公司 | 编码靶相关抗原表位的表达载体及其设计方法 |
EP1545610A4 (de) * | 2002-09-06 | 2006-11-08 | Mannkind Corp | Epitop-sequenzen |
US8343502B2 (en) | 2002-12-16 | 2013-01-01 | Globeimmune, Inc. | Yeast-based vaccines as immunotherapy |
EP1581174B1 (de) | 2002-12-16 | 2018-04-25 | GlobeImmune, Inc. | Impfstoffe auf hefebasis als immuntherapie |
WO2005010190A1 (en) * | 2003-07-22 | 2005-02-03 | Ludwig Institute For Cancer Research | Ssx-2 peptides presented by hla class ii molucules |
EP1833506B1 (de) * | 2004-12-29 | 2015-08-26 | Mannkind Corporation | Verwendung von zubereitungen, die verschiedene tumor-assoziierte antigene als impfstoffe gegen krebs enthalten |
MX2007008010A (es) * | 2004-12-29 | 2007-09-07 | Mannkind Corp | Metodos para desviar celulas cd4+ en la induccion de una inmuno respuesta. |
WO2006138568A2 (en) * | 2005-06-17 | 2006-12-28 | Mannkind Corporation | Multivalent entrain-and-amplify immunotherapeutics for carcinoma |
KR20080026181A (ko) | 2005-06-17 | 2008-03-24 | 맨카인드 코포레이션 | 암세포 및 종양 기질에 발현된 우성 및 준우성 에피토프에대한 다가 면역반응을 유발하기 위한 방법 및 조성물 |
BRPI0708446A2 (pt) | 2006-03-01 | 2011-06-07 | Janssen Pharmaceutica Nv | tratamento de cáncer combinando agente de linfodepleção com ctls e citocinas |
CA2646329C (en) | 2006-03-20 | 2018-07-03 | The Regents Of The University Of California | Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
WO2008008541A2 (en) * | 2006-07-14 | 2008-01-17 | Mannkind Corporation | Methods to elicit, enhance and sustain immune responses against mhc class-i restricted epitopes, for prophylactic or therapeutic purposes |
EP2089423B1 (de) * | 2006-09-21 | 2016-10-26 | Vaxil Biotherapeutics Ltd. | Antigenspezifische multi-epitop-impfstoffe |
CN101246176B (zh) * | 2007-02-13 | 2013-06-05 | 许洋 | 鳞状细胞癌抗原阴性宫颈癌血清蛋白质检测的质谱试剂及其制备方法 |
US8940298B2 (en) | 2007-09-04 | 2015-01-27 | The Regents Of The University Of California | High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection |
ES2712732T3 (es) | 2009-02-17 | 2019-05-14 | Cornell Res Foundation Inc | Métodos y kits para el diagnóstico de cáncer y la predicción de valor terapéutico |
CA2782333C (en) | 2009-12-02 | 2019-06-04 | Imaginab, Inc. | J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
US20130224249A1 (en) * | 2010-09-03 | 2013-08-29 | Ludwig Institute For Cancer Research Ltd. | Recombinant trypanosoma cruzi cells useful as anti-cancer immune agents |
SG10201604236RA (en) * | 2011-05-26 | 2016-07-28 | Geneius Biotechnology Investments Llc | Modulated Immunodominance Therapy |
CN107817348A (zh) * | 2012-09-05 | 2018-03-20 | 亚利桑那州评议委员会,亚利桑那州法人团体,代理和代表亚利桑那州立大学 | 发现治疗靶标的方法 |
EA034110B1 (ru) * | 2013-03-15 | 2019-12-27 | Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания | Противораковые вакцины и способы лечения с их применением |
JP2016535989A (ja) | 2013-11-01 | 2016-11-24 | ファイザー・インク | 前立腺関連抗原を発現させるためのベクター |
CN104761644A (zh) * | 2014-01-03 | 2015-07-08 | 百奇生物科技(苏州)有限公司 | 大肠杆菌表达的融合蛋白mbp-mart-1及其制备和应用 |
CN103837688A (zh) * | 2014-03-27 | 2014-06-04 | 吉林农业大学 | 一种检测犬猫弓形虫抗体的间接elisa试剂盒 |
CN113403338A (zh) | 2014-03-28 | 2021-09-17 | 华盛顿大学商业中心 | 乳腺癌和卵巢癌疫苗 |
US20170266269A1 (en) * | 2014-03-28 | 2017-09-21 | University Of Washington Through Its Center For Commercialization | Methods of identifying antigens for vaccines |
US9549914B2 (en) | 2014-04-03 | 2017-01-24 | The Johns Hopkins University | Treatment of human cytomegalovirus by modulating Wnt |
TWI707872B (zh) * | 2014-05-29 | 2020-10-21 | 美商宏觀基因股份有限公司 | 特異性結合多種癌症抗原的三特異性結合分子和其使用方法 |
CN104142401B (zh) * | 2014-07-25 | 2016-04-20 | 北京普恩光德生物科技开发有限公司 | 膀胱肿瘤相关抗原检测试剂盒 |
WO2016128060A1 (en) * | 2015-02-12 | 2016-08-18 | Biontech Ag | Predicting t cell epitopes useful for vaccination |
CN105067731B (zh) * | 2015-06-05 | 2017-06-16 | 中国农业科学院兰州兽医研究所 | 一种弓形虫感染后血清中生物标记物的筛选方法及筛选出的生物标记物的应用 |
AU2016304764C1 (en) | 2015-08-07 | 2023-06-01 | Imaginab, Inc. | Antigen binding constructs to target molecules |
CN105175498A (zh) * | 2015-10-09 | 2015-12-23 | 深圳市康尔诺生物技术有限公司 | 一种宫颈癌相关的热休克蛋白复合物及其应用 |
WO2017096247A1 (en) | 2015-12-04 | 2017-06-08 | Mayo Foundation For Medical Education And Research | Methods and vaccines for inducing immune responses to multiple different mhc molecules |
KR102319839B1 (ko) * | 2015-12-23 | 2021-11-01 | 메디진 이뮤노테라피스 게엠바하 | 항원-특이적 tcr의 신규 생성 |
MA45455A (fr) * | 2016-06-27 | 2019-05-01 | Juno Therapeutics Inc | Procédé d'identification d'épitopes peptidiques, molécules qui se lient à de tels épitopes et utilisations associées |
EP3573997A4 (de) * | 2017-01-24 | 2020-12-09 | Abexxa Biologics, Inc. | Verfahren und zusammensetzungen zum targeting eines komplexes, der nicht klassisches hla-i und neoantigen umfasst, bei krebs |
WO2018147960A1 (en) | 2017-02-08 | 2018-08-16 | Imaginab, Inc. | Extension sequences for diabodies |
WO2018217852A1 (en) * | 2017-05-23 | 2018-11-29 | Gettysburg College | Crispr based tool for characterizing bacterial serovar diversity |
CN112813099A (zh) * | 2019-11-15 | 2021-05-18 | 上海细胞治疗集团有限公司 | 一种在活化的t细胞中具有高活性的启动子 |
WO2024050547A2 (en) * | 2022-09-02 | 2024-03-07 | Hunterian Medicine Llc | Compact bidirectional promoters for gene expression |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4439199A (en) * | 1980-02-19 | 1984-03-27 | Alza Corporation | Method for administering immunopotentiator |
US4683199A (en) * | 1983-01-31 | 1987-07-28 | Sloan-Kettering Institute For Cancer Research | Interleukin-2 dependent cytotoxic T-cell clones |
US5168062A (en) * | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
US5132213A (en) * | 1986-10-02 | 1992-07-21 | Massachusetts Institute Of Technology | Method for producing proteins and polypeptides using ubiquitin fusions |
US5196321A (en) * | 1986-10-02 | 1993-03-23 | Massachusetts Institute Of Technology | Methods for in vitro cleavage of ubiquitin fusion proteins |
US5093242A (en) * | 1986-10-02 | 1992-03-03 | Massachusetts Institute Of Technology | Methods of generating desired amino-terminal residues in proteins |
US4937190A (en) * | 1987-10-15 | 1990-06-26 | Wisconsin Alumni Research Foundation | Translation enhancer |
ATE115187T1 (de) * | 1988-02-12 | 1994-12-15 | Commw Scient Ind Res Org | Poxvirus-vektoren. |
US6723832B1 (en) * | 1996-10-03 | 2004-04-20 | Ludwig Institute For Cancer Research | Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof |
US5703055A (en) * | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
WO1991006866A2 (en) | 1989-11-03 | 1991-05-16 | Morton Donald L | Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
DE4143467C2 (de) * | 1991-05-17 | 1995-02-09 | Max Planck Gesellschaft | Peptidmotiv und dessen Verwendung |
US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
DE4228458A1 (de) * | 1992-08-27 | 1994-06-01 | Beiersdorf Ag | Multicistronische Expressionseinheiten und deren Verwendung |
US5744316A (en) * | 1992-12-22 | 1998-04-28 | Ludwig Institute For Cancer Research | Isolated, tyrosinase derived peptides and uses thereof |
US5989565A (en) | 1993-01-29 | 1999-11-23 | University Of Pittsburgh | Elution and identification of T cell epitopes from viable cells |
JPH08508252A (ja) * | 1993-03-17 | 1996-09-03 | アメリカ合衆国 | 小胞体シグナル配列ペプチドと少なくとも1個の他のペプチドをエンコードする核酸配列を含有する免疫原性キメラ、及びこのキメラのワクチン及び疾患の治療における使用 |
US5679647A (en) * | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
US5478556A (en) * | 1994-02-28 | 1995-12-26 | Elliott; Robert L. | Vaccination of cancer patients using tumor-associated antigens mixed with interleukin-2 and granulocyte-macrophage colony stimulating factor |
US5874560A (en) * | 1994-04-22 | 1999-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Melanoma antigens and their use in diagnostic and therapeutic methods |
DE4423392A1 (de) * | 1994-07-04 | 1996-01-11 | Birsner & Grob Biotech Gmbh | Verfahren zur Identifizierung antigener Peptide |
FR2722208B1 (fr) * | 1994-07-05 | 1996-10-04 | Inst Nat Sante Rech Med | Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique |
US5962428A (en) * | 1995-03-30 | 1999-10-05 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
US5698396A (en) * | 1995-06-07 | 1997-12-16 | Ludwig Institute For Cancer Research | Method for identifying auto-immunoreactive substances from a subject |
DK0900380T3 (da) * | 1996-04-26 | 2003-11-03 | Seed Capital Investments | Fremgangsmåde til udvælgelse og fremstilling af T-celle-peptid-epitoper og vacciner indeholdende disse udvalgte epitoper |
US6287756B1 (en) * | 1997-05-05 | 2001-09-11 | Ludwig Institute For Cancer Research | Methods for determining presence of cancer in a sample by determining expression of an SSX gene |
WO1999001283A1 (fr) | 1997-07-03 | 1999-01-14 | Matsushita Electric Industrial Co., Ltd. | Tete d'impression a jets d'encre et procede de fabrication de cette tete |
FR2794370B1 (fr) * | 1999-06-03 | 2003-10-17 | Biovector Therapeutics | Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination |
EP1118860A1 (de) * | 2000-01-21 | 2001-07-25 | Rijksuniversiteit te Leiden | Verfahren zur Auswahl und zur Herstellung von T-Zellen-Peptidepitopen sowie darauf basierten Impfstoffen |
US20030215425A1 (en) * | 2001-12-07 | 2003-11-20 | Simard John J. L. | Epitope synchronization in antigen presenting cells |
US6861234B1 (en) * | 2000-04-28 | 2005-03-01 | Mannkind Corporation | Method of epitope discovery |
US20040236514A1 (en) * | 2001-12-13 | 2004-11-25 | Lee Stephen C. | Controlling distribution of epitopes in polypeptide sequences |
-
2001
- 2001-04-27 EP EP10178756A patent/EP2278023A1/de not_active Withdrawn
- 2001-04-27 JP JP2001579836A patent/JP2003535824A/ja active Pending
- 2001-04-27 DE DE60142615T patent/DE60142615D1/de not_active Expired - Lifetime
- 2001-04-27 EP EP01930922A patent/EP1276896B1/de not_active Expired - Lifetime
- 2001-04-27 AU AU5741001A patent/AU5741001A/xx active Pending
- 2001-04-27 EP EP10170170A patent/EP2248910A1/de not_active Withdrawn
- 2001-04-27 CN CN01812119A patent/CN1440462A/zh active Pending
- 2001-04-27 EP EP10178766A patent/EP2278024A1/de not_active Withdrawn
- 2001-04-27 AT AT01930922T patent/ATE474931T1/de not_active IP Right Cessation
- 2001-04-27 DK DK01930922.8T patent/DK1276896T3/da active
- 2001-04-27 CA CA002405363A patent/CA2405363A1/en not_active Abandoned
- 2001-04-27 NZ NZ521715A patent/NZ521715A/en not_active IP Right Cessation
- 2001-04-27 AU AU2001257410A patent/AU2001257410B8/en not_active Ceased
- 2001-04-27 ES ES01930922T patent/ES2347762T3/es not_active Expired - Lifetime
- 2001-04-27 WO PCT/US2001/013806 patent/WO2001082963A2/en active Application Filing
-
2003
- 2003-06-09 HK HK03104029.4A patent/HK1053333A1/xx not_active IP Right Cessation
-
2007
- 2007-03-07 US US11/683,397 patent/US20070269464A1/en not_active Abandoned
-
2010
- 2010-12-14 AU AU2010251790A patent/AU2010251790B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
WO2001082963A3 (en) | 2002-04-11 |
AU2010251790A1 (en) | 2011-01-06 |
EP2278024A1 (de) | 2011-01-26 |
EP2248910A1 (de) | 2010-11-10 |
CA2405363A1 (en) | 2001-11-08 |
NZ521715A (en) | 2008-01-31 |
EP1276896A2 (de) | 2003-01-22 |
AU5741001A (en) | 2001-11-12 |
AU2001257410B2 (en) | 2006-08-24 |
ATE474931T1 (de) | 2010-08-15 |
JP2003535824A (ja) | 2003-12-02 |
ES2347762T3 (es) | 2010-11-04 |
EP1276896B1 (de) | 2010-07-21 |
AU2010251790B2 (en) | 2013-02-07 |
EP2278023A1 (de) | 2011-01-26 |
CN1440462A (zh) | 2003-09-03 |
DK1276896T3 (da) | 2010-10-18 |
US20070269464A1 (en) | 2007-11-22 |
WO2001082963A2 (en) | 2001-11-08 |
HK1053333A1 (en) | 2003-10-17 |
AU2001257410B8 (en) | 2006-12-21 |
AU2001257410B9 (en) | 2006-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60142615D1 (de) | Epitop-synchronisierung in antigen präsentierenden zellen | |
NO20015073D0 (no) | Vaksiner | |
SI1928492T1 (sl) | Imunoloĺ ka uporaba imunomodulatornih spojin za cepivo in protiinfekcijsko bolezensko terapijo | |
EA200702633A1 (ru) | Вакцина против малярии | |
CY1115308T1 (el) | Συνθεσεις εμβολιου οι οποιες περιεχουν ανοσοενισχυτικο εκδοχο σαπωνινης | |
DE69030172D1 (de) | Impfstoffe gegen Krebs und Infektionskrankheiten | |
CY1113546T1 (el) | Μικρορευστοποιημενα γαλακτωματα ελαιου σε νερο και συνθεσεις εμβολιων | |
ATE489969T1 (de) | Verpackte virusartige partikel in kombination mit cpg zur verwendung als adjuvantien mit allergenen. herstellungsverfahren und verwendung | |
DE60012042D1 (de) | Entepneumovirus und entsprechendes impfstoff | |
WO2008096831A1 (ja) | 癌の治療剤 | |
BRPI0518091A2 (pt) | mycobacterium, mÉtodo para permitir com que uma mycobacterium escape a partir de endossomos e preparaÇço para uma vacina | |
WO2008000261A3 (en) | Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails | |
WO2006113622A3 (en) | Direct vaccination of the bone marrow | |
EA200701440A1 (ru) | Композиции для иммунизации против микобактерий | |
TR200102034T2 (tr) | Anti kanser aşılaması için antikorların kullanılması | |
JP2014516538A5 (de) | ||
WO2003057823A3 (en) | Epitope synchronization in antigen presenting cells | |
DE69720065T2 (de) | Therapeutische anwendungen von antigenen oder epitopen assoziert mit unvollständiger zellulärer peptidprozesierung , z.b.: exprimiert in rma-s zellen transfiziert mit b7-1 gen | |
DE602006020679D1 (de) | Zusammensetzung zur immunisierung gegen mykobakterien | |
BR112017019776A2 (pt) | proteínas de fusão que compreendem glicoproteínas de superfície de alfavírus modificadas e antígeno associado a tumor e métodos dos mesmos | |
DK56389D0 (da) | Forhindring og behandling af retroviralt frembragte sygdomme | |
BR9306187A (pt) | Vacina bacterin-toxóide pasteurella haemolytica tipo a-1 | |
ATE526035T1 (de) | Tollwut-impfstoff | |
FR2796282B1 (fr) | Vaccin inactive contre la calicivirose feline | |
CY1117601T1 (el) | Ανασυνδυασμενα εμβολια κατα κωπηποδων καλιγιδων (θαλασσιων ψειρων) και αλληλουχιες αντιγονων αυτων |